| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |